Recommended Adult Immunization Schedule for ages 19 …

Recommended Adult Immunization Schedule

for ages 19 years or older

UNITED STATES

2024

Vaccines in the Adult Immunization Schedule*

Vaccine COVID-19 vaccine Haemophilus influenzae type b vaccine

Abbreviation(s) 1vCOV-mRNA 1vCOV-aPS

Hib

Trade name(s)

Comirnaty?/Pfizer-BioNTech COVID-19 Vaccine Spikevax?/Moderna COVID-19 Vaccine

Novavax COVID-19 Vaccine

ActHIB? Hiberix? PedvaxHIB?

Hepatitis A vaccine Hepatitis A and hepatitis B vaccine

Hepatitis B vaccine

Human papillomavirus vaccine Influenza vaccine (inactivated) Influenza vaccine (live, attenuated) Influenza vaccine (recombinant) Measles, mumps, and rubella vaccine

HepA HepA-HepB

HepB

HPV IIV4 LAIV4 RIV4 MMR

Havrix? Vaqta?

Twinrix?

Engerix-B? Heplisav-B? PreHevbrio? Recombivax HB?

Gardasil 9?

Many brands

FluMist? Quadrivalent

Flublok? Quadrivalent

M-M-R II? Priorix?

Meningococcal serogroups A, C, W, Y vaccine Meningococcal serogroup B vaccine

MenACWY-CRM MenACWY-TT

MenB-4C MenB-FHbp

Menveo? MenQuadfi?

Bexsero? Trumenba?

Meningococcal serogroup A, B, C, W, Y vaccine Mpox vaccine Pneumococcal conjugate vaccine Pneumococcal polysaccharide vaccine Poliovirus vaccine Respiratory syncytial virus vaccine

MenACWY-TT/ MenB-FHbp Mpox PCV15 PCV20 PPSV23 IPV

RSV

PenbrayaTM

Jynneos? VaxneuvanceTM Prevnar 20TM Pneumovax 23? Ipol? Arexvy? AbrysvoTM

Tetanus and diphtheria toxoids

Td

Tenivac? TdvaxTM

Tetanus and diphtheria toxoids and acellular pertussis vaccine

Tdap

Adacel? Boostrix?

Varicella vaccine

VAR

Varivax?

Zoster vaccine, recombinant

RZV

Shingrix

*Administer recommended vaccines if vaccination history is incomplete or unknown. Do not restart or add doses to vaccine

series if there are extended intervals between doses. The use of trade names is for identification purposes only and does not imply endorsement by the ACIP or CDC.

2/29/2024

How to use the adult immunization schedule

1 Determine

2 Assess need

3 4 Review vaccine

Review

5 Review new

recommended for additional

types, dosing

contraindications or updated

vaccinations

recommended

frequencies and

and precautions

ACIP guidance

by age

vaccinations by

intervals, and

for vaccine types (Addendum)

(Table 1)

medical

considerations for (Appendix)

condition or

special situations

other indication

(Notes)

(Table 2)

Recommended by the Advisory Committee on Immunization Practices (vaccines/ acip) and approved by the Centers for Disease Control and Prevention (), American College of Physicians (), American Academy of Family Physicians (aafp. org), American College of Obstetricians and Gynecologists (), American College of Nurse-Midwives (), American Academy of Physician Associates (aapa. org), American Pharmacists Association (), and Society for Healthcare Epidemiology of America (shea-).

Report

y Suspected cases of reportable vaccine-preventable diseases or outbreaks to the local or state health department

y Clinically significant adverse events to the Vaccine Adverse Event Reporting System at vaers. or 8008227967

Questions or comments

Contact cdc-info or 800-CDC-INFO (800-232-4636), in English or Spanish, 8 a.m.?8 p.m. ET, Monday through Friday, excluding holidays.

Download the CDC Vaccine Schedules app for providers at vaccines/schedules/hcp/schedule-app.html.

Helpful information

y Complete Advisory Committee on Immunization Practices (ACIP) recommendations:

vaccines/hcp/acip-recs/index.html

y ACIP Shared Clinical Decision-Making Recommendations:

vaccines/acip/acip-scdm-faqs.html

y General Best Practice Guidelines for Immunization

vaccines/hcp/acip-recs/general-recs/index.html

y Vaccine information statements: vaccines/hcp/vis/index.html

y Manual for the Surveillance of Vaccine-Preventable Diseases

(including case identification and outbreak response): vaccines/pubs/surv-manual

Scan QR code for access to online schedule

CS310021-D

Table 1 Recommended Adult Immunization Schedule by Age Group, United States, 2024

Vaccine

COVID-19

Influenza inactivated (IIV4) or Influenza recombinant (RIV4)

or

Influenza live, attenuated (LAIV4)

Respiratory Syncytial Virus (RSV)

Tetanus, diphtheria, pertussis (Tdap or Td)

Measles, mumps, rubella (MMR)

Varicella (VAR)

Zoster recombinant (RZV)

Human papillomavirus (HPV)

Pneumococcal (PCV15, PCV20, PPSV23)

Hepatitis A (HepA)

Hepatitis B (HepB)

Meningococcal A, C, W, Y (MenACWY)

Meningococcal B (MenB)

Haemophilus influenzae type b (Hib)

Mpox

19?26 years

27?49 years

50?64 years

1 or more doses of updated (2023?2024 Formula) vaccine (See Notes)

65 years

1 dose annually

1 dose annually

or

Seasonal administration during pregnancy. See Notes.

1 dose Tdap each pregnancy; 1 dose Td/Tdap for wound management (see notes) 1 dose Tdap, then Td or Tdap booster every 10 years

1 or 2 doses depending on indication (if born in 1957 or later)

2 doses (if born in 1980 or later)

2 doses

2 doses for immunocompromising conditions (see notes)

2 doses

2 or 3 doses depending on age at initial vaccination or condition

27 through 45 years

2, 3, or 4 doses depending on vaccine

>60 years For healthcare personnel,

see notes

See Notes See Notes

2, 3, or 4 doses depending on v2a, c3c, ionre4 odor sceosnddeipteiondning on vaccine or condition

1 or 2 doses depending on indication, see notes for booster recommendations

19 through 23 years

2 or 3 doses depending on vaccine and indication, see notes for booster recommendations 1 or 3 doses depending on indication

Recommended vaccination for adults who meet age requirement, lack documentation of vaccination, or lack evidence of immunity

Recommended vaccination for adults with an additional risk factor or another indication

Recommended vaccination based on shared clinical decision-making

No recommendation/ Not applicable

Table 2 Recommended Adult Immunization Schedule by Medical Condition or Other Indication, United States, 2024

Always use this table in conjunction with Table 1 and the Notes that follow. Medical conditions or indications are often not mutually exclusive. If multiple medical conditions or indications are present, refer to guidance in all relevant columns. See Notes for medical conditions or indications not listed.

VACCINE

Pregnancy

Immunocompromised (excluding HIV infection)

HIV infection CD4 percentage and count

................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download